Skip to main content
Erschienen in: World Journal of Surgical Oncology 1/2012

Open Access 01.12.2012 | Case report

Precursor B-cell lymphoblastic leukemia of the arm mimicking neurogenic tumor: case report

verfasst von: Xiu-fang Sui, Wei-yong Liu, Wen Guo, Fang Xiao, Xing Yu

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2012

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Precursor B-cell lymphoblastic lymphoma (PBLL) is an infrequent subtype of lymphoblastic lymphoma (LBL) that commonly affected site for the diagnosis is the skin, followed by the head and neck. In this report, we presented a special case of PBLL located at the left arm and detected with magnetic resonance imaging (MRI) and ultrasonography (US). This kind of PBLL is similar to a peripheral nerve tumor in clinical and radiographic manifestation.
Hinweise

Electronic supplementary material

The online version of this article (doi:10.​1186/​1477-7819-10-140) contains supplementary material, which is available to authorized users.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XFS carried out the study design and writing. WYL and WG helped to draft the manuscript and participated in the literature search. XY performed the operation on the patient. FX performed acquisition of data and helped to draft the manuscript. All authors read and approved the final manuscript.
Abkürzungen
ALL
Acute lymphoblastic leukemia
CNS
Central nervous system
CSF
Cerebrospinal fluid
H & E
Haematoxylin and eosin
LBL
Lymphoblastic lymphoma
LDH
Serum lactate dehydrogenase
MRI
Magnetic resonance imaging
NHL
Non-Hodgkin’s lymphoma
PBLL
Precursor B-cell lymphoblastic lymphoma
RBC
Red blood cell
US
Ultrasound
WBC
White blood cells
WHO
World Health Organization.

Background

It is already documented that lymphoblastic lymphoma (LBL) is an uncommon entity of non-Hodgkin’s lymphoma (NHL) with an incidence of less than 1% for B-cell LBL among all NHLs [1, 2]. B-cell LBL is composed of immature lymphocytes that express precursor and B-cell markers. Although 80% of precursor B-cell neoplasms present as acute leukemia, a small proportion could manifest as a mass lesion [3]. We report here a 22-year-old man with an unusual precursor B-cell lymphoblastic lymphoma (PBLL) presenting as a mass in the left arm and extending along the neurovascular bundle, similar to a neurogenic tumor.

Case presentation

A 22-year-old man was referred to a physician complaining of severe pain for 6 months from a progressively growing mass in the left arm. Medical history was unremarkable and the patient was not receiving any medication. He denied weight loss, night sweats and other unusual symptoms. Physical examination identified a fusiform palpable mass extending from the middle of the left arm to the elbow, combined with muscle weakness and numbness on forced flexion and supination. The laboratory results of kidney and liver functional tests, as well as the white blood cell counts and serum lactate dehydrogenase (LDH) levels, were within the normal range. The cerebrospinal fluid immunocytochemical analysis, bone marrow aspiration and biopsy showed negative for any malignancy. In addition, no positive symptoms were found on chest radiography or abdominal ultrasound (US).
Magnetic resonance imaging (MRI) revealed a well-defined mass located in the medial compartment of the left arm, with homogeneous and intermediate signal intensity on the axial T2-weighted image (Figure 1A) and isointense to skeletal muscle on the axial T1-weighted image (Figure 1B). The unusual thickened median nerve was completely encased by the lesion. The axial enhanced T1-weighted image (Figure 1C) and axial fat-saturated enhanced T1-weighted image (Figure 1D) mainly showed mainly uniform enhancement in accordance with the median nerve. The coronal fat-suppression proton-density fast spin echo image showed the mass longitudinally extended along the neurovascular bundle in extension to the median nerve with measures of 10 × 2 × 2 cm (Figure 1E). Well-defined margins were noticed on the coronal blade fat-suppression proton-density image (Figure 1F).
High-resolution US established a marked hypoechoic lesion on the left distal arm. The hypoechoic lesion showed a clear round halo which was completely and concentrically encased in the median nerve in transverse sonograms. The median nerve was much larger than normal and was characterized by swollen fascicles (Figure 2A). Longitudinal sonograms revealed the well-defined lesion extending along the median nerve (Figure 2B). Color Doppler sonography demonstrated avascular flow signals in the lesion (Figure 2C). The margin of the biceps brachii muscle slightly abutting the mass showed some hyervascularization on the color Doppler image (Figure 2D), while the basilic vein and ulnar nerve were normal.
Through surgery, a well-defined and fusiform mass was found on the left arm. The tumor extending along the neurovascular bundle and in continuity with the median nerve seemed to originate from the median nerve. After resection of the fragile fleshy mass, the marked swollen median nerve was also noticed (Figure 3). The median nerve was completely encased by the mass.
Histologic examination revealed a diffuse dense monomorphic infiltration from small to intermediate-sized lymphoblasts (Figure 4A) showing scant cytoplasm and irregular nuclei with a high mitotic rate (Figure 4B), infiltrating among the fibro-fatty tissue (Figure 4C). Based on the immunohistochemical analysis, most of the lymphocytes stained positively for CD20, TDT, CD45, CD99, CD34, CD43, and negatively for CD3. Immunostaining for Ki-67 showed positive immunostaining of more than 90% of the lymphocytes. A diagnosis of precursor B-cell lymphoblastic lymphoma (PBLL) was rendered.
Clinical symptoms including severe pain and numbness were relieved soon after the surgical procedure of decompression. Local radiotherapy was applied to his left arm. PET and Gallium scintigraphy were not performed at diagnosis under cost constraints. He received two cycles of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy in the following 2 months. The patient was readmitted to our hospital due to persistent headache for a week before initiation of further chemotherapy. Cerebrospinal fluid (CSF) examination showed glucose 2.90 mmol/L, increased protein at 0.60 g/L, 90% mononuclear cells, 10% polykaryocytes, karyocyte count 90 × 106/L, and no red blood cells (RBCs). The diagnosis of central nervous system (CNS) involvement was established. MRI of the brain was unremarkable. Neck, chest, and abdomino-pelvic sonography revealed no other involvement site except for a few axillary lymph nodes less than 10 mm in size. The patient died of multiple organ failure early in the course of high-dose methylprednisolone treatment shortly after being readmitted. Request for autopsy was denied.

Discussion

LBL is a rare disease that shares the same biologic features as the acute lymphoblastic leukemia (ALL). Indeed, LBL and ALL are considered to be a single entity (lymphoblastic leukemia/lymphoma T and B types) in the World Health Organization (WHO) classification of precursor lymphoid neoplasms [4]. LBL is committed to the T-cell lineage (T-LBL), B-(B-LBL), or NK-cell lineage (NK-LBL) with an incidence of less than 2% within all NHLs, 1.7% for T- and less than 1% for B-lymphoblastic lymphoma respectively, even fewer for NK-lymphoblastic lymphoma [2]. T-cell type usually presents with a mediastinal mass and cervical lymphadenopathy. However, B-LBL often occurs within skin and bone involvement, except for a small proportion involving soft tissue and presenting with a mass lesion [5, 6]. Localized invasion of peripheral nerves of extra-nodal LBL, a unique uncommon subtype, was termed as neurolymphomatosis [7].
The presenting signs and symptoms with LBL are shown in the primary sites where the disease is involved [8]. However, the clinical signs and symptoms are usually unspecific, which may pose a diagnostic problem. A technologically less complex needle biopsy may yield a diagnosis. However, our case was not possible to safely perform this procedure, as the biopsy may place the patient at very high risk of nerve and vessel injury. Therefore, a more invasive procedure should be performed for more reliable diagnosis. Imaging studies play a very important role to illustrate the relationship between the lesion and the adjacent tissue before the operation.
The MRI findings in our patient are similar to those of musculoskeletal lymphoma in the previous studies [9, 10], such as predominantly homogeneous, intermediate signal intensity between those of fat and muscle on the T2-weighted image, and equal signal intensity compared with normal muscle on the T1-weighted image. The uncommon growth pattern of extension along the neurovascular bundle may represent infiltration along the lymphatic system.
The advantage of sonography in comparison with MRI is its ability to trace the imaged nerve segments in a single study and with superior resolution [11]. The encasement of the median nerve with loss of fascicular discrimination resembled the sonography of peripheral nerve compression, which seemed to occur secondary to schwannoma deriving from the nerve sheath [12]. However, three differences from nerve compression were still considered in this case. First, the sonographic appearance of the transverse median nerve was round-shaped in our patient, which was different from the somewhat flattened appearance in the entrapment neuropathies. Second, the nerve commonly showed a focal thinning in diameter at the site of direct compression, while our patient demonstrated marked swelling of the median nerve without reduction in nerve diameter. Third, color Doppler sonography in our patient revealed scarce intra- and perineural Doppler signals in the median nerve, whereas an increase in intraneural and perineural flow signals in color Doppler or power Doppler images was commonly seen in nerve compression [11].
PBLL is a highly aggressive subtype of lymphoma, with frequent bone marrow involvement, and a 5% to 10% incidence of CNS involvement [1]. Positive CNS involvement is defined as the presence of 5 × 106/L or more white blood cells (WBCs) on CSF cytospin. The presence of CNS leukemia is an adverse prognostic factor and a potentially fatal complication of lymphoma [13]. The main cause of death in neurolymphomatosis is disseminated disease with associated multi-organ failure [14], as was seen in our patient. Peripheral neuropathy as a complication of lymphoma is not common, affecting only 0.1% to 2.0% of patients. The tumor may arise within aberrant lymph nodes, behaving as an infiltrative lesion instead of a compartmental condition [4, 5]. The variable cells might possess stronger affinity to endothelial cells at the blood-nerve barrier, which would allow easier passage of the lymphoma cells into the peripheral nervous system. Sonographic and MRI assessment of the extent of the damaged median nerve in our patient was very beneficial. Explorative surgical treatment was very challenging in this case. Nonetheless the reasons for the procedure may be discerned in general: Firstly, proven median nerve compression inside the lesion surgical decompression was advocated; Secondly, an exact diagnostic work-up was mandatory to achieve an establishment of reliably histopathologic diagnosis.

Conclusions

We experienced a PBLL presenting as a mass, and posing diagnostic difficulties for the referring clinician and radiologist. This could be mistaken for an enlarged neurogenic tumor.
Written informed consent was obtained from the patient’s parents for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Acknowledgements

We thank Ms Lin-li Yao from the Pathologic Departments of Anhui Medical University for her technical assistance in PBLL analyses.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XFS carried out the study design and writing. WYL and WG helped to draft the manuscript and participated in the literature search. XY performed the operation on the patient. FX performed acquisition of data and helped to draft the manuscript. All authors read and approved the final manuscript.
Literatur
1.
Zurück zum Zitat Hoelzer D, Gökbuget N: Treatment of lymphoblastic lymphoma in adults. Best Pract Res Clin Haematol. 2002, 15: 713-728. 10.1053/beha.2002.0230.CrossRefPubMed Hoelzer D, Gökbuget N: Treatment of lymphoblastic lymphoma in adults. Best Pract Res Clin Haematol. 2002, 15: 713-728. 10.1053/beha.2002.0230.CrossRefPubMed
2.
Zurück zum Zitat Sweetenham JW: Treatment of lymphoblastic lymphoma in adults. Oncology (Williston Park). 2009, 23: 1015-1020. Sweetenham JW: Treatment of lymphoblastic lymphoma in adults. Oncology (Williston Park). 2009, 23: 1015-1020.
3.
Zurück zum Zitat Zanation AM, Ebert CS, Coffey CS, Dubin MG, Rose AS: Precursor B-cell lymphoblastic lymphoma presenting as an isolated external ear swelling in a two-year-old child. Int J Pediatr Otorhinolaryngol. 2005, 69: 695-699. 10.1016/j.ijporl.2004.12.001.CrossRefPubMed Zanation AM, Ebert CS, Coffey CS, Dubin MG, Rose AS: Precursor B-cell lymphoblastic lymphoma presenting as an isolated external ear swelling in a two-year-old child. Int J Pediatr Otorhinolaryngol. 2005, 69: 695-699. 10.1016/j.ijporl.2004.12.001.CrossRefPubMed
4.
Zurück zum Zitat Abou-Mourad Y, Barnett M: Further considerations about lymphoblastic lymphoma. Oncology (Williston Park). 2009, 23: 1020-1026. Abou-Mourad Y, Barnett M: Further considerations about lymphoblastic lymphoma. Oncology (Williston Park). 2009, 23: 1020-1026.
5.
Zurück zum Zitat Ducassou S, Ferlay C, Bergeron C, Girard S, Laureys G, Pacquement H: Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. Br J Haematol. 2011, 152: 441-451. 10.1111/j.1365-2141.2010.08541.x.CrossRefPubMed Ducassou S, Ferlay C, Bergeron C, Girard S, Laureys G, Pacquement H: Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951. Br J Haematol. 2011, 152: 441-451. 10.1111/j.1365-2141.2010.08541.x.CrossRefPubMed
6.
Zurück zum Zitat Nagasaki A, Miyagi T, Nakazato T, Taira N, Ohshima K, Kikuchi M: Very late central nervous system relapse in a patient with B cell lymphoblastic lymphoma. Acta Haematol. 2004, 112: 212-216. 10.1159/000081275.CrossRefPubMed Nagasaki A, Miyagi T, Nakazato T, Taira N, Ohshima K, Kikuchi M: Very late central nervous system relapse in a patient with B cell lymphoblastic lymphoma. Acta Haematol. 2004, 112: 212-216. 10.1159/000081275.CrossRefPubMed
8.
Zurück zum Zitat Weinstein HJ, Hudson MM, Link MP: Precursor B and Precursor T-Cell Lymphoblastic Lymphoma. Pediatric Oncology. Volume 9. 2007, Springer, Berlin, 199-213. Weinstein HJ, Hudson MM, Link MP: Precursor B and Precursor T-Cell Lymphoblastic Lymphoma. Pediatric Oncology. Volume 9. 2007, Springer, Berlin, 199-213.
9.
Zurück zum Zitat Suresh S, Saifuddin A, O'Donnell P: Lymphoma presenting as a musculoskeletal soft tissue mass: MRI findings in 24 cases. Eur Radiol. 2008, 18: 2628-2634. 10.1007/s00330-008-1014-x.CrossRefPubMed Suresh S, Saifuddin A, O'Donnell P: Lymphoma presenting as a musculoskeletal soft tissue mass: MRI findings in 24 cases. Eur Radiol. 2008, 18: 2628-2634. 10.1007/s00330-008-1014-x.CrossRefPubMed
10.
Zurück zum Zitat Metzler JP, Fleckenstein JL, Vuitch F, Frenkel EP: Skeletal muscle lymphoma: MRI evaluation. Magn Reson Imaging. 1992, 10: 491-494. 10.1016/0730-725X(92)90522-2.CrossRefPubMed Metzler JP, Fleckenstein JL, Vuitch F, Frenkel EP: Skeletal muscle lymphoma: MRI evaluation. Magn Reson Imaging. 1992, 10: 491-494. 10.1016/0730-725X(92)90522-2.CrossRefPubMed
11.
Zurück zum Zitat Beekman R, Visser LH: High-resolution sonography of the peripheral nervous system - a review of the literature. Eur J Neurol. 2004, 11: 305-314. 10.1111/j.1468-1331.2004.00773.x.CrossRefPubMed Beekman R, Visser LH: High-resolution sonography of the peripheral nervous system - a review of the literature. Eur J Neurol. 2004, 11: 305-314. 10.1111/j.1468-1331.2004.00773.x.CrossRefPubMed
12.
Zurück zum Zitat Gruber H, Glodny B, Bendix N, Tzankov A, Peer S: High-resolution ultrasound of peripheral neurogenic tumors. Eur Radiol. 2007, 17: 2880-2888. 10.1007/s00330-007-0645-7.CrossRefPubMed Gruber H, Glodny B, Bendix N, Tzankov A, Peer S: High-resolution ultrasound of peripheral neurogenic tumors. Eur Radiol. 2007, 17: 2880-2888. 10.1007/s00330-007-0645-7.CrossRefPubMed
13.
Zurück zum Zitat Abla O, Naqvi A, Ye C, Bhattacharjee R, Shago M, Abdelhaleem M, Weitzman S: Leptomeningeal precursor B-cell lymphoblastic lymphoma in a child with minimal bone marrow involvement. J Pediatr Hematol Oncol. 2004, 26: 469-472. 10.1097/00043426-200407000-00015.CrossRefPubMed Abla O, Naqvi A, Ye C, Bhattacharjee R, Shago M, Abdelhaleem M, Weitzman S: Leptomeningeal precursor B-cell lymphoblastic lymphoma in a child with minimal bone marrow involvement. J Pediatr Hematol Oncol. 2004, 26: 469-472. 10.1097/00043426-200407000-00015.CrossRefPubMed
14.
Zurück zum Zitat Odabasi Z, Parrott JH, Reddy VV, Oh SJ: Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst. 2001, 6: 197-203. 10.1046/j.1529-8027.2001.01018.x.CrossRefPubMed Odabasi Z, Parrott JH, Reddy VV, Oh SJ: Neurolymphomatosis associated with muscle and cerebral involvement caused by natural killer cell lymphoma: a case report and review of literature. J Peripher Nerv Syst. 2001, 6: 197-203. 10.1046/j.1529-8027.2001.01018.x.CrossRefPubMed
Metadaten
Titel
Precursor B-cell lymphoblastic leukemia of the arm mimicking neurogenic tumor: case report
verfasst von
Xiu-fang Sui
Wei-yong Liu
Wen Guo
Fang Xiao
Xing Yu
Publikationsdatum
01.12.2012
Verlag
BioMed Central
Erschienen in
World Journal of Surgical Oncology / Ausgabe 1/2012
Elektronische ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-10-140

Weitere Artikel der Ausgabe 1/2012

World Journal of Surgical Oncology 1/2012 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.